Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MindBio Therapeutics Corp. has successfully completed a private placement, raising $200,390 from five investors and issuing 6,909,986 shares. Additionally, Riverfort Global Opportunities converted CAD$50,000 of its loan into 1,000,000 shares, supporting MindBio’s ongoing Phase 2B trials expected to finish in 2025.
For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.